文献速递瓣膜病与结构性心脏病

人工智能辅助获取与解读筛查主动脉瓣狭窄

Artificial Intelligence-Enabled Acquisition and Interpretation for Screening Aortic Stenosis.
PubMed 文献 · JAMA Cardiol · 2026-08-28

该诊断研究开发并验证了检测中度及以上主动脉瓣狭窄的深度学习算法,并在新手操作者中使用AI引导的聚焦心脏超声进行前瞻性评估。模型在内部测试和地理上不同的验证队列中均表现出极好的区分度(AUROC均为0.99)。前瞻性新手操作者队列中,96.6%的检查适合自动分析,敏感度为93%、特异度为96%;专家复核AI阳性及不可解读检查将阳性预测值从49.4%提升至91.1%。

要点

  • AI引导的聚焦心脏超声可由新手操作者获取,并能准确检测中度及以上主动脉瓣狭窄。
  • 模型在内部测试及亚利桑那、佛罗里达验证队列中AUROC均为0.99。
  • 专家复核AI阳性及不可解读检查可提高阳性预测值至91.1%。

核心结论

  • 深度学习算法在各验证队列中能准确检测中度及以上主动脉瓣狭窄。
  • 新手操作者能获取AI引导的聚焦心脏超声检查,从而实现中度及以上主动脉瓣狭窄的准确检测。

研究设计与样本

  • 诊断研究,包括回顾性算法开发与验证以及前瞻性评估,在Mayo Clinic中西部、亚利桑那和佛罗里达院区开展。
  • 模型开发使用6753例患者,并在内部验证(n=852)、内部测试(n=844)和验证(n=1912)队列中评估。
  • 在经验丰富的超声技师获取的聚焦心脏超声(n=602)以及新手操作者前瞻性获取的聚焦心脏超声(n=1302)上评估性能。
  • 回顾性模型开发与验证队列包含2005年1月至2022年9月进行的检查;前瞻性研究在2024年6月至8月及2025年6月至9月两个入组期开展,两期参与者合并为最终前瞻性队列。

主要发现

  • 模型在内部测试队列中表现出极好的区分度(AUROC,0.99;95% CI,0.98-1.00)。
  • 在亚利桑那验证队列中AUROC为0.99(95% CI,0.97-1.00),在佛罗里达验证队列中AUROC为0.99(95% CI,0.96-1.00)。
  • 在经验丰富超声技师获取的聚焦心脏超声检查中,敏感度为95%(95% CI,82-99),特异度为97%(95% CI,95-98)。
  • 在前瞻性新手操作者队列中,1302次检查中有1258次(96.6%)适合自动分析,敏感度为93%(95% CI,82-99),特异度为96%(95% CI,95-97)。
  • 专家复核AI阳性及不可解读检查将阳性预测值从49.4%提高至91.1%,敏感度为85.4%。

临床怎么用

  • AI引导的聚焦心脏超声可由新手操作者获取,用于检测中度及以上主动脉瓣狭窄。
  • 专家复核AI阳性及不可解读检查可提高阳性预测值。
  • 该策略可能扩展超声心动图资源有限环境中主动脉瓣狭窄检测的可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Timely identification of aortic stenosis (AS) is essential for appropriate clinical management, yet screening remains limited by dependence on comprehensive echocardiography and trained imaging personnel. OBJECTIVE: To develop and validate a deep learning algorithm for detection of moderate or greater AS and prospectively evaluate its performance using artificial intelligence (AI)-guided focused cardiac ultrasound (FoCUS) acquired by novice operators. DESIGN, SETTING, AND PARTICIPANTS: This diagnostic study included retrospective algorithm development and validation and prospective evaluation of AI-guided FoCUS across Mayo Clinic sites in the Midwest, Arizona, and Florida. The model was developed using 6753 patients and evaluated in internal validation (n = 852), internal test (n = 844), and validation (n = 1912) cohorts. Performance was assessed on FoCUS acquired by experienced sonographers (n = 602) and prospectively by novice operators (n = 1302). The retrospective model development and validation cohorts comprised studies performed from January 2005 through September 2022. Prospective study was conducted in 2 enrollment periods from June to August 2024 and from June to September 2025. Participants from both periods were combined to comprise the final prospective cohort. EXPOSURE: AI-guided FoCUS acquisition and automated deep learning-based assessment for detection of moderate or greater AS. MAIN OUTCOMES AND MEASURES: Detection of moderate or greater AS. Performance was assessed using area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, and positive predictive value. RESULTS: The model demonstrated excellent discrimination in the internal test cohort (AUROC, 0.99; 95% CI, 0.98-1.00) and geographically distinct validation cohorts in Arizona (AUROC, 0.99; 95% CI, 0.97-1.00) and Florida (AUROC, 0.99; 95% CI, 0.96-1.00). Among FoCUS examinations acquired by experienced sonographers, sensitivity was 95% (95% CI, 82-99) and specificity was 97% (95% CI, 95-98). In the prospective novice-operator cohort, 1258 of 1302 examinations (96.6%) were suitable for automated analysis. Sensitivity was 93% (95% CI, 82-99) and specificity was 96% (95% CI, 95-97). Expert review of AI-positive and uninterpretable examinations increased the positive predictive value from 49.4% to 91.1%, with sensitivity of 85.4%. CONCLUSIONS AND RELEVANCE: A deep learning algorithm accurately detected moderate or greater AS across validation cohorts in this study. In prospective evaluation, novice operators were able to acquire AI-guided FoCUS examinations that enabled accurate detection of moderate or greater AS. These findings support a scalable strategy that may expand access to AS detection in settings with limited echocardiography resources.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Lee E, Naser JA, Kane CJ, et al. Artificial Intelligence-Enabled Acquisition and Interpretation for Screening Aortic Stenosis. JAMA Cardiol. 2026. PMID: 42661496. doi:10.1001/jamacardio.2026.3829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。